Sunil Verma, MD, senior vice president and global head of oncology, medical, at AstraZeneca, discusses safety findings of the TOPAZ-1 trial.
Sunil Verma, MD, senior vice president and global head of oncology, medical, at AstraZeneca, discusses the safety findings of the TOPAZ-1 trial.
TOPAZ-1 results were initially presented at the recent American Society of Clinical Oncology Gastrointestinal Cancers Symposium and discussed during the Cholangiocarcinoma Foundation 2022 meeting held February 23-25 in Salt Lake City, Utah, and virtually.
Transcript:
Can you discuss the safety results in the TOPAZ-1 trial, which saw higher discontinuation rates for the chemo-only group?
So, when you see that, it suggests a couple of things. One, it tells you about the patient performance status and the patient's ability to tolerate a regimen, which may be directed by the tumor burden. When you see a response more in the combination where the patients are able to stay longer, that's telling us that the tumor burden starts to lessen where the patients are then able to stay on treatment and maintain on treatment much longer as a result. It's maybe less so the reflection of this traditional side effect profile, but it's more so a reflection of the side effect profile, along with an activity profile that allows the patient's performance status and quality of life to be better so that they can stay on treatment much longer, versus a patient who may be just on standard of care who is not driving the clinical benefit and, as a result, is maybe not able to tolerate the standard of care as effectively.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More